Hospice
Hospice originally was a resting place for weary travelers in the fourth century and continued so for centuries. Even the monks in a 15th-century Switzerland hospice raised and trained Saint Bernard dogs, establishing the legendary portrait of the keg carrying dog. In the 19th century, a religious order established hospices for the dying in Ireland and London and in 1967, St Christopher's hospice began. In the United States, there were only 59 identifiable hospices in 1978, which expanded to 440 by 1981. In subsequent years, the number of hospices grew exponentially to 4200 now.
Along with this, hospice growth was the expected regulations and laws. In 1982, the Joint Commission on Accreditation of Hospitals (now the Joint Commission on the Accreditation of Healthcare Organizations) started the Hospice Project which established standards for hospice care and continued through the late 1980s. At about the same time, the Hospice Medicare Benefit was enacted as part of TEFRA (Tax Equity and Fiscal Responsibility Act) on September 3, 1982 Because there is no clear-cut answer to the origins of the ''6'' months to live, the next issue is the role of the attending physician. In the initial legislation, the attending physician was only involved in the initial certification of hospice care and, as is evident over the years, often disappears in the management of the patient as does the systematic peer review of appropriateness of care.
When the Medicare hospice benefit was offered in the early 1980s, the expectation was that the majority of patients would have cancer, and this was the case for several years. In reviewing the Medicare claims data from 1990, Christakis and Escarce 1 reported a median length of survival after enrollment of 36 days, with over 8% living more than a year. They also found that patients with noncancerous diseases including stroke, congestive heart failure, dementia, and chronic obstructive pulmonary disease lived longer than most cancer patients. Thus, it appears that the paradigm is shifting regarding disease referrals to hospice. As more and expensive newer cancer treatments evolve broadening the horizon of treatment, fewer patients will opt for hospice and the referral void will be filled with patients with other chronic diseases. Or, as Dr Callahan 2 writes:
Death is not conquered, but we spend more money to keep it a bay.
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Palliative Medicine
As hospice flourished throughout the 1980s, so did physician uneasiness and discontent. Perceived barriers to hospice were Prognostication; Lack of physician leadership and misperceptions; Isolation from mainstream acute care medicine; Financial constraints.
Fueling the impetus for palliative medicine was the significant impact of chronic diseases on the growing, aging US population. Palliative medicine redefined the pathophysiology of the dying process. In this light, prognosis for chronic disease periods were defined as stable (years to months), symptomatic (months to weeks), and final (weeks to days). Currently, existing approaches vary widely from inpatient consultation only to a fully functional model with the common goal of managing complex illnesses. Approximately 20% of community hospitals have a palliative medicine program. Cost savings rather than revenue generating are significant for these programs. In a recent study, Morrison et al 3 reported net savings of US$1.3 million per year for an average of 400-bed hospital containing an interdisciplinary palliative care team. 3 For too many of these patients, ''that's not hospice; its last rites'' Dr John W. Rowe Former Chairman and Chief Executive Aetna
Open Access Hospice
Recent interest has focused on the concept of open access hospice. 4, 5 By comparison standard hospice:
Forgoes all life sustaining treatment including chemotherapy and radiation therapy; Allows some life-prolonging treatment as long as with this treatment survival is less than 6 months; Treatment decisions are based on cost.
Whereas, open access hospice or complex care management advocates for advanced medical treatments. As highlighted in a recent New York Times article, 4 several successful programs are underway at Aetna, United Healthcare and the Continuum Hospice Care program. However, the major caveat is a minimum census of over 400 patients, which comprises only 2.5% of all hospices. 5 For the times they are a-changin' Bob Dylan
Hospice Reform
In 2006, 40% of Medicare beneficiaries opted for the hospice benefit. One-third was referred during the last week of life. Medicare spends US$10 billon yearly with 90% of the reimbursement for routine home care (US$135 per day) regardless of visits done. 6 In June of this year, the Medicare Payment Advisory Commission (MedPac) 7 released their report and chapter 6 is entitled ''Reforming Medicare's hospice benefit.'' Highlights of this 29-page report include:
Congressional oversight of hospice was lacking in recent years; Tripling of the Medicare hospice spending to US$10 billion between 2000 and 2007, with a projected doubling over the next decade; Increase in hospice providers by 1000 during this time period, nearly all for-profit; A strong correlation exists between length of stay and profitability; In 2008, 90% of reimbursement was for routine home care regardless of whether an actual visit was done; 2 of 3 noncancer diagnoses with longer stays.
The report goes on recommending 4 broad-based changes including ensuring greater physician involvement in hospice care. Sounds familiar! In sum, changes are in the wind and reading the MedPac report is a worthwhile use of time as is appreciating the past in anticipation of the future.
